Amyotrophic lateral sclerosis (ALS) and other motor neuron diseases (MNDs) are major global causes of death. However, their global incidence ...
The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...
A strategic focus on collaboration between industry and academia is essential for sustaining growth and competitiveness in the pharma sector ...
The ALS Association is the world's leading funder of amyotrophic lateral sclerosis (ALS) research -- -- The Hoffman ALS ...
Calgary Herald on MSN
'Continue his legacy': Kelsie Snow to talk about her and her late husband Chris's experience with ALS
Kelsie and Chris Snow met in their early 20s when they were sports writers for the Boston Globe in Chris’s hometown. Chris ...
J&J is also running mid-stage trials of a tau active immunotherapy codenamed JNJ-2056 for Alzheimer's, while other active tau ...
Stocktwits on MSN
Pasithea Therapeutics Stock Rockets To Best Day In 4 Years On Massive Share Offering Amid ALS Drug Momentum
Shares surged as investors reacted to a large equity offering combined with renewed optimism around Pasithea’s expanding ...
The incredible fundraising feats and dedication to others in the USA have been recognised with the official declaration of Rod Caborn Day.
Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...
TipRanks on MSN
Neurizon Strengthens Board with Elanco Executive Appointment
Neurizon Therapeutics Limited has appointed Ms. Justine Conway, Global Head of Business Development at Elanco Animal Health, as a Board Observer. This appointment underscores the strong partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback